comparemela.com

Amardeep Manhas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stella buys Field Trip ketamine assets | Crain s Chicago Business

Walgreens earnings disappoint, Augmedic's big venture-capital haul and more in today's Health Pulse.

United statesNew yorkRush university medical centerFrank phillipsAmardeep manhasJohn driscollJames kehoeMujeeb jafferiEugene lipovPhilippe sanchezKent mcgaughyKevin hykesShields health solutionEvidity health capitalTawain main biotechnology companyHealth pulse

Ketamine News: PharmaTher Begins FDA Filing For KETARX Application, Stella Acquires Field Trip Assets - PharmaTher Holdings (OTC:PHRRF), Field Trip Health (OTC:FTHWF)

Specialty biotech company PharmaTher Holdings Ltd. (OTCQB: PHRRF) has filed a pre-submission facility correspondence in advance of its Abbreviated New Drug Application (ANDA) for its novel racemic ketamine KETARX to the FDA.

United statesNew yorkMujeeb jafferiEugene lipovAmardeep manhasOperation forces protocolPharmather holdings ltdVitruvias therapeutics incAbbreviated new drug applicationField tripReunion neuroscienceDual sympathetic resetStellate ganglion blockPost traumatic stress injurySpecial operation forces protocol

vimarsana © 2020. All Rights Reserved.